Company profile
Home | Avacta Life Sciences Limited
We develop safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer and pre|CISION platforms
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
SH01 | Transaction MzUyNzM2ODg1N2FkaXF6a2N4
Published 19 Jun 2026 18:36
SH01 | Transaction MzUyNzM2Nzc1MmFkaXF6a2N4
Published 19 Jun 2026 15:33
SH01 | Transaction MzUyMjI0ODE3NmFkaXF6a2N4 | Paper/PDF filed
Published 08 Jun 2026 23:02
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MTcyMDc1MWFkaXF6a2N4
Published 01 Nov 2024 08:50
SH01 | Transaction MzQ0MTcyMDQzM2FkaXF6a2N4
Published 01 Nov 2024 08:45
SH01 | Transaction MzQzODk0ODEwOGFkaXF6a2N4
Published 09 Oct 2024 04:40
AD01 | Transaction MzQzODQ1MTI0MmFkaXF6a2N4
Published 04 Oct 2024 04:16
SH01 | Transaction MzQzNTI0NzQxN2FkaXF6a2N4
Published 11 Sep 2024 07:28
Company registered at Companies House
1 Aug 2006 to 31 Jul 2009
Awaiting Public Summary
